{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:27:42Z","timestamp":1791836862668,"version":"4.3.4"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/rlu.0000000000000915","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T11:19:01Z","timestamp":1438168741000},"page":"21-27","source":"Crossref","is-referenced-by-count":40,"title":["90Y Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival"],"prefix":"10.1097","volume":"41","author":[{"given":"Minzhi","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Lahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Kokabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210204","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2008.02.090","article-title":"Diagnosis and treatment of hepatocellular carcinoma.","volume":"134","author":"El-Serag","year":"2008","journal-title":"Gastroenterology"},{"key":"R2-4-20210204","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.semradonc.2011.05.004","article-title":"Radioembolization for primary and metastatic liver cancer.","volume":"21","author":"Memon","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"R3-4-20210204","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.clcc.2011.12.002","article-title":"Yttrium-90 radioembolization as salvage therapy for colorectal cancer with liver metastases.","volume":"11","author":"Martin","year":"2012","journal-title":"Clin Colorectal Cancer"},{"key":"R4-4-20210204","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ijrobp.2009.07.006","article-title":"Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma.","volume":"77","author":"Inarrairaegui","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R5-4-20210204","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/COC.0b013e3181f47583","article-title":"Radioembolization for the treatment of liver tumors general principles.","volume":"35","author":"Kennedy","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"R6-4-20210204","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fphys.2013.00159","article-title":"Macrophages and chemokines as mediators of angiogenesis.","volume":"4","author":"Owen","year":"2013","journal-title":"Front Physiol"},{"key":"R7-4-20210204","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","article-title":"Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.","volume":"284","author":"Holash","year":"1999","journal-title":"Science"},{"key":"R8-4-20210204","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1148\/radiol.14131969","article-title":"Characteristics of primary and secondary hepatic malignancies associated with hepatopulmonary shunting.","volume":"271","author":"Gaba","year":"2014","journal-title":"Radiology"},{"key":"R9-4-20210204","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/COC.0b013e318168ef65","article-title":"Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution.","volume":"31","author":"Salem","year":"2008","journal-title":"Am J Clin Oncol"},{"key":"R10-4-20210204","first-page":"538376","article-title":"Radiographic parameters in predicting outcome of patients with hepatocellular carcinoma treated with yttrium-90 microsphere radioembolization.","volume":"2013","author":"Salem","year":"2013","journal-title":"ISRN Oncol"},{"key":"R11-4-20210204","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00270-007-9064-z","article-title":"Radioembolization with 90Y microspheres: angiographic and technical considerations.","volume":"30","author":"Lewandowski","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R12-4-20210204","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","article-title":"Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations.","volume":"17","author":"Salem","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"R13-4-20210204","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.jvir.2009.07.033","article-title":"Hepatic vein tumor thrombus as a risk factor for excessive pulmonary deposition of microspheres during TheraSphere therapy for unresectable hepatocellular carcinoma.","volume":"20","author":"Fleming","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"R14-4-20210204","first-page":"70","article-title":"Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99 m macroaggregated albumin.","volume":"35","author":"Leung","year":"1994","journal-title":"J Nucl Med"},{"key":"R15-4-20210204","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jvir.2009.08.013","article-title":"The role of tumor vascularity in predicting survival after yttrium-90 radioembolization for liver metastases.","volume":"20","author":"Sato","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"R16-4-20210204","first-page":"1201","article-title":"Arteriovenous shunts in patients with hepatic tumors.","volume":"38","author":"Ho","year":"1997","journal-title":"J Nucl Med"},{"key":"R17-4-20210204","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/ijc.28230","article-title":"Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.","volume":"133","author":"Schulze","year":"2013","journal-title":"Int J Cancer"},{"key":"R18-4-20210204","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ncb2977","article-title":"Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH.","volume":"16","author":"Urosevic","year":"2014","journal-title":"Nat Cell Biol"},{"key":"R19-4-20210204","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jvir.2012.04.007","article-title":"Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administration.","volume":"23","author":"Theysohn","year":"2012","journal-title":"J Vasc Interv Radiol"},{"key":"R20-4-20210204","first-page":"2015","article-title":"2014 (Resolution 17). Available at: .","year":"15","journal-title":"Accessed April"},{"key":"R21-4-20210204","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijrobp.2006.11.060","article-title":"Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.","volume":"68","author":"Kennedy","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R22-4-20210204","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1016\/j.jvir.2013.01.387","article-title":"Management of high hepatopulmonary shunt fractions in patients undergoing radioembolization.","volume":"24","author":"Tamrazi","year":"2013","journal-title":"J Vasc Interv Radiol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000000915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:12:49Z","timestamp":1620972769000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201601000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000000915","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}